1-arylsulfonyl-2-(Pyridylmethylsulfinyl) benzimidazoles as new proton pump inhibitor prodrugs

Molecules

Volumn 14, Issue 12, 2009, Pages 5247-5280

  Shin, Jai Moo ^a,b   Sachs, George ^a,b   Cho, Young Moon ^a,b   Garst, Michael ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c ALLERGAN INC   (United States)

Author keywords

Gastric acid secretion; Prodrug; Proton pump inhibitor

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; PRODRUG; PROTON PUMP INHIBITOR;

ARTICLE; BLOOD; CHEMISTRY; HUMAN; HYDROLYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

BENZIMIDAZOLES; BLOOD; HUMANS; HYDROLYSIS; MAGNETIC RESONANCE SPECTROSCOPY; PRODRUGS; PROTON PUMP INHIBITORS;

EID: 73949086137     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14125247     Document Type: Article

References (23)

1. Shin, J.M.; Cho, Y.M.; Sachs, G. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors. J. Am. Chem. Soc. 2004, 126, 7800-7811.
2. Shin, J.M.; Sachs, G., Restoration of acid secretion following treatment with proton pump inhibitors. Gastroenterology 2002, 123, 1588-1597.
3. Besancon, M.; Shin, J.M.; Mercier, F.; Munson, K.; Miller, M.; Hersey, S.; Sachs, G. Membrane topology and omeprazole labeling of the gastric H+, K(+)-adenosinetriphosphatase. Biochemistry 1993, 32, 2345-2355.
4. Shin, J.M.; Homerin, M.; Domagala, F.; Ficheux, H.; Sachs, G. Characterization of the inhibitory activity of tenatoprazole on the gastric H+, K+ -ATPase in vitro and in vivo. Biochem. Pharmacol. 2006, 71, 837-849.
5. Stedman, C.A.; Barclay, M.L. Review article: Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment. Pharmacol. Ther. 2000, 14, 963-978.
6. Richter, J.E.; Kahrilas, P.J.; Johanson, J.; Maton, P.; Breiter, J.R.; Hwang, C.; Marino, V.; Hamelin, B.; Levine, J.G. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Am. J. Gastroenterol. 2001, 96, 656-665.
7. Sachs, G.; Shin, J.M.; Pratha, V.; Hogan, D. Synthesis or rupture: Duration of acid inhibition by proton pump inhibitors. Drugs Today (Barc) 2003, 39 (Suppl. A), 11-14.
8. Gedda, K.; Scott, D.; Besancon, M.; Lorentzon, P.; Sachs, G. Turnover of the gastric H+, K(+)-adenosine triphosphatase alpha subunit and its effect on inhibition of rat gastric acid secretion. Gastroenterology 1995, 109, 1134-1141.
9. Sih, J.C.; Im, W.B.; Robert, A.; Graber, D.R.; Blakeman, D.P. Studies on (H(+)-K+)-ATPase inhibitors of gastric acid secretion. Prodrugs of 2-[(2-pyridinylmethyl)sulfinyl]benzimidazole proton-pump inhibitors. J. Med. Chem. 1991, 34, 1049-1062.
10. Alminger, T.; Larsson, H.; Lindberg, P.; Sunden, G. Novel pharmacological compounds. WO 87/02668, 1987.
11. Alminger, T.; Bergman, R.; Bundgaard, H., Lindberg, P.; Sunden, G. New benzimidazole derivatives A process for production thereof and a pharmaceutical composition containg the same. WO 88/03921, 1988.
12. Brandstrom, A.; Lindberg, P.; Sunden, G. Therapeutically active fluoro substituted benzimidazoles, processes for their preparation as well as their use. WO Pat. 91/09028, 1991.
13. Von Unge, S. Novel ethoxycarbonyloxymethyl derivatives of substituted benzimidazoles. WO Pat. 95/32957, 1995.
14. Brandstrom, A.; Lindberg, P.; Bergman, N.A.; Tekenbergs-Hjelte, L.; Ohlson, K.; Grundevik, I.; Nordberg, P.; Alminger, T. Chemical reactions of omeprazole and omeprazole analogues. V. Acta Chem. Scand. 1989, 43, 587-594.
15. Garst, M.; Sachs, G.; Shin, J.M. Prodrugs of proton pump inhibitors. US Pat. 6,897,227, 2005.
16. Garst, M.; Dolby, L.J.; Esfandiari, S.; MacKenzie, V.R.; Aveys, A.A., Jr.; Muchmore, D.X.; Cooper, G.K.; Malone, T.C. Process for preparing isomerically pure prodrugs of proton pump inhibitors. US Pat. 7,294,716. 2007.
17. Hunt, R.H.; Armstrong, D.; Yaghoobi, M.; James, C.; Chen, Y.; Leonard, J.; Shin, J.M.; Lee, E.; Tang-Liu, D.; Sachs, G. Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z. Aliment. Pharmacol. Ther. 2008, 28, 187-199.
18. +)ATPase. Nature 1981, 290, 159-161.
19. Cremlyn, R.J.W.; David, L.; Motwani, R. Sulfonohydrazides and related compounds. XIII. Sulfanilohydrazides. J. Chem. Soc. Perkin 1 1973, 500-503.
20. Cremlyn, R.J.; Bassin, J.P.; Farouk, S.; Potterton, M.; Mattu, T. Chlorosulfonation of N-phenylmorpholine, benzothiazole, 2-methylbenzothiazole, and triphenyloxazole. Phosphor. Sulfur Silicon 1992, 73, 107-120.
21. Kim, H.S.; Koh, Y.K.; Choi, J.H. Synthesis of thiazole-containing benzo-crown ethers. J. Heterocycl. Chem. 1998, 35, 177-181.
22. Lindner, E.; Weber, H. Stabilization of sulfonylium cations. Chem. Ber. 1968, 101, 2832-2836.
23. Cremlyn, R.J.; Pannell, R.W. Some sulfonyl derivatives of phenoxyacetamide. Aust. J. Chem. 1978, 31, 2669-2674.